Documente Academic
Documente Profesional
Documente Cultură
Cardio-hepatic syndrome
Alexandre Mebazaa
Department of Anesthesia & Critical Care
University Hospitals Saint Louis – Lariboisière, Paris, France
University Paris 7; INSERM – UMR 942
Conflict of interest
Short version: HFA/EUSEM/SAEM Eur Heart Journal 2015; Long version: Eur J Heart Failure 2015
‘Clinical scenario 2’ in the CCU:
dyspnoea + SBP 110-150 mmHg
Decompensated chronic
heart failure
• Dyspnoea develops gradually
• Gradual increase in body weight
• Systemic oedema
• Minimal pulmonary oedema
It is a systemic illness:
• Possible renal dysfunction
• Anaemia
• Low albumin levels
• Increased pulmonary congestion
• Systemic congestion
Acute heart failure = right & left ventricular failure:
results of meta-analysis
LV
failure
RAP - right atrial pressure
PCWP - pulmonary capillary wedge pressure Ishihara S et al (submitted for publication)
“Butterfly” pattern on chest X-ray
RV failure
RAP - right atrial pressure
PCWP - pulmonary capillary wedge pressure Ishihara S et al (submitted for publication)
Cardiorenal Syndrome
Type I
?
Acute setting ?
‘abrupt worsening
of cardiac function
(e.g. from ADHF)
eading to acute
kidney injury’
Ronco et al. JACC
Ronco C et al. J Am Coll2008, 52:1527-39
Card 2008, 52:1527-39
Effects of CVP, CI, SBP and PcwP on worsening
renal function In Acute Heart Failure patients
CVP (p<0.01) CI
Worsening Renal Function (%)
SBP PCWP
p=0.58
p=0.007
Ishihara S et al (submitted for publication)
Gheorghiade et al. Eur J Heart F 2010
Abstract of the review
« The main reason for hospitalization for acute heart failure is
CONGESTION, rather than low cardiac output ».
Normal Intra-tissular pressure = 0
Outflow pressure
Effect of Heart
MAP > Tissular pressure Failure
Stable on Organ
CHF
Congestion
MAP < Tissular pressure
AHF
± high PAP
volume loading
PA
RAP ARVF
TR
RV
Liver/Kidney
CONGESTION
Liver dysfunction in AHF:
Clinical characteristics
Alk Phosphatase Transaminases
+ +
+ +++ +++
+ +
and cytolysis
(increased transaminanses)
+ +
+ +++ +++
+ +
and cytolysis
(increased transaminanses)
inotropes
Epinephrine
0.5
Norepinephrine
0.4
0.3
Dopamine
Dobutamine
0.2
Whole cohort
0.1
Diuretics
Levosimendan
0.0
Vasodilatators
0 5 10 15 20 25 30
Days
Online, free access
SEVERITY SCORE
• Congestion is the main disease in acute heart failure
• Novel therapies, such as novel vasodilators, aim at
reducing congestion
• « time is muscle «
Main messages (2)
• There are evidence for a cardio-liver syndrome in
AHF
• Cholestasis is associated with signs of congestion
• Hepatolysis is associated with decreased blood flow
In summary
• There are evidence for a cardio-liver
syndrome in AHF
• Cholestasis is associated with signs of
congestion
• Hepatolysis is associated with decreased
blood flow